Effects of Vildagliptin on Glucose Control Over 24 Weeks in Patients With Type 2 Diabetes Inadequately Controlled With Metformin

Diabetes Care - United States
doi 10.2337/dc06-1732
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Diabetes Association

Related search

Comparison of Nateglinide and Gliclazide in Combination With Metformin, for Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled on Maximum Doses of Metformin Alone

Diabetic Medicine
Internal MedicineEndocrinologyMetabolismDiabetes
2006English

Effects of Dapagliflozin on 24-Hour Glycemic Control in Patients With Type 2 Diabetes: A Randomized Controlled Trial

Diabetes Technology and Therapeutics
MedicineEndocrinologyMedical Laboratory TechnologyMetabolismDiabetes
2018English

Pdb18 - Clinical & Economic Effectiveness of Using Vildagliptin in Adult Patients With Type 2 Diabetes Undergoing Metformin Monotherapy With Unsatisfactory Glycemic Control

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

A Prospective Open Labelled Study of Effect of Vildagliptin With Metformin in Patients With Type 2 Diabetes Mellitus

International Journal of Basic & Clinical Pharmacology
2019English

Efficacy and Safety Over 26 Weeks of an Oral Treatment Strategy Including Sitagliptin Compared With an Injectable Treatment Strategy With Liraglutide in Patients With Type 2 Diabetes Mellitus Inadequately Controlled on Metformin: A Randomised Clinical Trial

Diabetologia
Internal MedicineEndocrinologyMetabolismDiabetes
2013English

Combination of Empagliflozin and Linagliptin as Second-Line Therapy in Subjects With Type 2 Diabetes Inadequately Controlled on Metformin

Diabetes Care
Internal MedicineEndocrinologyAdvancedMetabolismSpecialized NursingDiabetes
2015English

Efficacy and Safety of Diacerein in Patients With Inadequately Controlled Type 2 Diabetes: A Randomized Controlled Trial

Diabetes Care
Internal MedicineEndocrinologyAdvancedMetabolismSpecialized NursingDiabetes
2017English

Dose-Dependent Effects of the Once-Daily GLP-1 Receptor Agonist Lixisenatide in Patients With Type 2 Diabetes Inadequately Controlled With Metformin: A Randomized, Double-Blind, Placebo-Controlled Trial

Diabetic Medicine
Internal MedicineEndocrinologyMetabolismDiabetes
2010English

Potential Protective Effects of Metformin on Ocular Complications in Patients With Type 2 Diabetes

2020English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy